Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction
Year: 2020
Type: article
Source: Circulation
Authors: Yu Horiuchi, Nicholas Wettersten, Mitul P. Patel, Christian Mueller, Sean-Xavier Neath, Robert H. Christenson, Nils G. Morgenthaler, James McCord, Richard M. Nowak, Gary M. Vilke, Lori B. Daniels, Judd E. Hollander, Fred S. Apple, Chad M. Cannon, John T. Nagurney, Donald Schreiber, Christopher deFilippi, Christopher Hogan, Deborah B. Diercks, Gary Headden, Alexander T. Limkakeng, Inder Anand, Alan H.B. Wu, Stefan Ebmeyer, Allan S. Jaffe, W. Frank Peacock, Alan Maisel
Institutions: University of California San Diego, Mitsui Memorial Hospital, University Hospital of Basel, University of Maryland, Baltimore, Charité – Universitätsmedizin Berlin, Henry Ford Health, Henry Ford Hospital, Thomas Jefferson University, University of Minnesota, Hennepin County Medical Center, University of Kansas Medical Center, Massachusetts General Hospital, Stanford Medicine, Stanford University, Virginia Commonwealth University, The University of Texas Southwestern Medical Center, Medical University of South Carolina, Duke Medical Center, Minneapolis VA Medical Center, University of California, San Francisco, Thermo Fisher Scientific (Germany), Mayo Clinic
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3080233357